Comprehensive molecular cytogenetic analysis of mantle cell lymphoma.

被引：0
|
作者：
Leupolt, E
Bullinger, L
Bentz, M
Ott, G
Müller-Hermelink, HK
Barth, TFE
Möller, P
Lichter, P
Döhner, H
Stilgenbauer, S
机构：
[1] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany
[2] Univ Wurzburg, Dept Pathol, D-97070 Wurzburg, Germany
[3] Univ Ulm, Dept Pathol, D-89069 Ulm, Germany
[4] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2315
引用
收藏
页码：517A / 517A
页数：1
相关论文
共 50 条
  • [31] Gallbladder mantle cell lymphoma. An unusual clinical presentation
    Mercado, M. R.
    Sapia, S.
    Barraza, G.
    Navas, R.
    Ortega, E.
    Munoz, C.
    Sanchez, M. F.
    Herrero, J.
    Martinez, A.
    HISTOPATHOLOGY, 2012, 61 : 121 - 121
  • [32] CD5 negative mantle cell lymphoma.
    Liu, Z
    Dong, H
    Gorczyca, W
    Tsang, P
    Cohen, P
    Stephenson, C
    Berger, C
    Wu, CD
    Weisberger, J
    BLOOD, 2001, 98 (11) : 126A - 126A
  • [33] Outcomes of autologous and allogeneic BMT for mantle cell lymphoma.
    Kasamon, YL
    Jones, RJ
    Diehl, LF
    Nayer, H
    Borowitz, MJ
    Garrett-Mayer, E
    Ambinder, RF
    Abrams, RA
    Zhang, Z
    Flinn, IW
    BLOOD, 2004, 104 (11) : 257A - 257A
  • [34] Validation of the Mantle Cell Lymphoma Prognostic Index (MIPI): A Valuable Tool for Risk Stratification in Mantle Cell Lymphoma.
    Smith, Stephen Douglas
    Hsi, Eric D.
    Bolwell, Brian J.
    Maggiotto, Amanda
    Effinger, Meagan
    Sweetenham, John William
    BLOOD, 2009, 114 (22) : 1058 - 1059
  • [35] A combination of molecular cytogenetic analyses reveals novel recurrent breakpoints in Mantle cell lymphoma
    Salaverria, Itziar
    Bea, Silvia
    Pla, Laura
    Espinet, Blanca
    Camps, Jordi
    Carrio, Anna
    Colomer, Dolors
    Costa, Dolors
    Miro, Rosa
    Sole, Francesc
    Campo, Elias
    CANCER RESEARCH, 2006, 66 (08)
  • [36] The impact of early stem cell transplantation on the prognosis of mantle cell lymphoma.
    Dreger, P
    Martin, S
    Kröger, N
    Kuse, R
    Sonnen, R
    Glass, B
    Parwaresch, R
    Kneba, M
    Schmitz, N
    Haas, R
    BLOOD, 1999, 94 (10) : 172A - 172A
  • [37] Dendritic cell-based therapy for the treatment of mantle cell lymphoma.
    Munger, CM
    Hentzen, A
    Vose, JM
    Bociek, RG
    Joshi, SS
    BLOOD, 2003, 102 (11) : 106A - 106A
  • [38] Potential molecular mechanism of bcl-1/IgH gene rearrangement in mantle cell lymphoma.
    Sun, WJ
    Lin, MF
    Kellner, U
    Parwaresch, R
    BLOOD, 2002, 100 (11) : 286B - 286B
  • [39] Dose dense, high intensity therapy for mantle cell lymphoma.
    Rizzieri, DA
    Gockerman, JP
    Moore, JO
    DeCastro, C
    Long, GD
    Vredenburgh, JJ
    Niedzwiecki, D
    Edwards, J
    Prosnitz, L
    Gasparetto, C
    Morris, A
    Lassiter, M
    Davis, P
    Chao, NJ
    BLOOD, 2001, 98 (11) : 681A - 682A
  • [40] TREATMENT OF RELAPSING OR REFRACTORY MANTLE CELL LYMPHOMA. UNICENTRIC STUDY
    Marc, Sorigue
    Juan-Manuel, Sancho
    Lluis, Virgili
    Miriam, Moreno
    Cristina, Motllo
    Gustavo, Tapia
    Susanna, Gassiot
    Alberto, Pineda
    Jose-Luis, Mate
    Laura, Abril
    Monica, Linares
    Clara, Maluquer
    Edurne, Sarrate
    Ana, Triguero
    Neus, Ruiz-Xiville
    Anna, Torrent
    Susana, Vives
    Christelle, Ferra
    Blanca, Xicoy
    Montserrat, Batlle
    Gladys, Ibarra
    Immaculada, Portal
    Jose-Tomas, Navarro
    Evarist, Feliu
    Josep-Maria, Ribera
    HAEMATOLOGICA, 2016, 101 : 207 - 208
12345